$0.26
+0.05 (+21.86%)
Open$0.22
Previous Close$0.21
Day High$0.26
Day Low$0.21
52W High$1.65
52W Low$0.21
Volume—
Avg Volume3.75M
Market Cap38.55M
P/E Ratio—
EPS$-0.33
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.95M | 2.89M | 2.41M |
| Net Income | -877,894 | -779,690 | -617,534 |
| Profit Margin | -29.8% | -27.0% | -25.7% |
| EBITDA | -957,867 | -819,475 | -798,278 |
| Free Cash Flow | -748,445 | -747,364 | -598,338 |
| Rev Growth | +6.0% | +2.0% | +0.0% |
| Debt/Equity | 0.66 | 0.66 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |